PKCε inhibitor peptide,myristoylated
Product Specifications
UNSPSC Description
PKCε inhibitor peptide,myristoylated (Myr‐PKC -) is a cell permeable myristic acid conjugated PKC peptide inhibitor that attenuates NO release in cultured human umbilical vein endothelial cells (HUVECs)[1].
Target Antigen
PKC
Type
Peptides
Related Pathways
Epigenetics;TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pkcε-inhibitor-peptide-myristoylated.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC(CCCCCCCCCCCCC)=O)CCC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N1[C@H](C(N[C@H](C(O)=O)[C@@H](C)O)=O)CCC1)=O)CCCCN)=O)CC(C)C)=O)CO)=O)C(C)C)=O)C
Molecular Weight
1054.32
References & Citations
[1]Castro J, et al. The Effects of Novel Myristoylated PKC Epsilon Peptide Modulators on Real‐Time Nitric Oxide Release in Human Umbilical Vein Endothelial Cells. The FASEB Journal, 2020, 34(S1): 1-1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P5888/PKCε-inhibitor-peptide-myristoylated-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P5888/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC214594L1V 200 µL
Calcitonin (CALCA) (NM_001741) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 